Trilostane Basic Info
| Product Name | Trilostane |
| Alias | modrenal |
| CAS | 13647-35-3 |
| MF | C20H27NO3 |
| MW | 329.43 |
| EINECS | 237-133-0 |
| Purity | 99.50% |
| Grade | Pharmaceutical Grade |
| Appearance | White Crystal Powder |
| Brand Nmae | HKYC |
| Standard | USP |
| Stock | Mass Stock |
| Packing Methods | designed disguised packing ways, 100% pass custom guarantee |
| Delivery time | within 18 hours after payment confirmed |
| Payment | T/T, Western Union,Money Gram , Bitcoin |
| Usage | Trilostane is an inhibitor of steroid biosynthesis. Used as an adrenocortical suppressant. Used in the treatment of breast cancer. |
Trilostane Description:
Trilostane is an inhibitor of 3β -hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome and primary hyperaldosteronism. These are both disorders where excess amounts of corticosteroid hormones are produced in the body. Corticosteroids are essential for the body to make use of carbohydrates, fats and proteins and for a normal response to stress. They are also necessary for the regulation of salt and water balance in the body. Trilostane helps prevent the production of corticosteroids, controlling the symptoms associated with these disorders.
Trilostane can also be useful in the treatment of breast cancer that has relapsed in women who have gone through menopause.
Trilostane Applications:
Trilostane is used in the treatment of Cushing's syndrome. It is normally used in short-term treatment until permanent therapy is possible.
Trilostane blocks an enzyme involved in the production of several steroids including cortisol. Inhibiting this enzyme inhibits the production of cortisol. In Cushing's syndrome, the adrenal gland overproduces steroids. Although steroids are important for various functions of the body, too much can cause problems. Trilostane reduces the amount of steroids produced by the adrenal gland.
Trilostane produces suppression of the adrenal cortex by inhibiting enzymatic conversion of steroids by 3-beta-hydroxysteroid dehydrogenase/delta 5,4 ketosteroid isomerase, thus blocking synthesis of adrenal steroids.
Trilostane is usually given by the inhaled route for direct effect on bronchial smooth muscle. This is usually achieved through a metered dose inhaler (MDI), nebulizer or other proprietary delivery devices (e.g. Rotahaler or Autohaler). In these forms of delivery, the maximal effect of salbutamol can take place within five to 20 minutes of dosing, though some relief is immediately seen. It can also be given intravenously.
Trilostane is also used in the treatment of bronchial asthma, asthmatic bronchitis, emphysema, patients bronchospasm.
